Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 2 Months to 59 Months

Vitamin C to shorten hospital stay for children with severe pneumonia

Official title: Efficacy of Vitamin C as an Adjunct to Standard Treatment in Severe Pneumonia in Children Under Five Years of Age: A Clinical Comparison

Run by Children's Hospital and Institute of Child Health, Multan · NCT07414693 · Data updated 2026-11-12

This trial will test whether giving vitamin C along with usual treatment helps children under five with severe pneumonia get better faster and leave the hospital sooner.

More Vitamin D Deficiency trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages2 Months to 59 Months
SexAll
Enrollment90 (estimated)
SponsorChildren's Hospital and Institute of Child Health, Multan
Government
Locations1 site (Multan Khurd, Punjab Province)
StatusRecruiting
StartedAugust 28, 2025
Main results expectedFebruary 27, 2026
Study endsFebruary 27, 2026
Registry record updatedFebruary 17, 2026
Trial IDNCT07414693 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–59 months admitted within 48 hours with signs of severe pneumonia and without chronic lung disease or immunosuppression are the intended participants.

Probably not a fit

Children with congenital heart disease, chronic respiratory illnesses (like asthma, bronchiectasis, or cystic fibrosis), or weakened immune systems were excluded and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized Phase 4 trial enrolls 90 children aged 2–59 months admitted to a single pediatric hospital in Multan with WHO-defined severe pneumonia. After parental consent, participants are randomly assigned to receive standard antibiotic treatment with or without added vitamin C. Children with congenital heart disease, chronic respiratory illnesses, or immunosuppression are excluded. The primary outcome is length of hospital stay, with clinical recovery measured by resolution of danger signs and respiratory symptoms.

Why it matters

Potential benefit: If successful, adding vitamin C could shorten hospital stays for young children with severe pneumonia and reduce treatment costs and hospital resource use.

How similar studies have gone: Previous studies of vitamin C for respiratory infections and critical illness have shown mixed results, and evidence specifically in young children with severe pneumonia is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* presenting with severe pneumonia
* ≤ 48-hours duration

Exclusion Criteria:

* Congenital heart disease
* Children with chronic respiratory illnesses i.e. Asthma, post tuberculosis bronchiectasis and cystic fibrosis
* Immunosuppressed i.e. primary immune deficiency, malignancy, on steroid therapy

Where it's running

  • Children Hospital and Institute of Child Health
    Multan Khurd, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.